Your browser doesn't support javascript.
loading
Outcomes and differences by occluded vessel after endovascular thrombectomy for isolated medium vessel occlusions.
Matsukawa, Hidetoshi; Uchida, Kazutaka; Cunningham, Conor; Sowlat, Mohammad-Mahdi; Elawady, Sameh Samir; Maier, Ilko; Jabbour, Pascal; Kim, Joon-Tae; Wolfe, Stacey Quintero; Rai, Ansaar; Starke, Robert M; Psychogios, Marios-Nikos; Shaban, Amir; Arthur, Adam; Cuellar, Hugo; Howard, Brian M; Alawieh, Ali; Romano, Daniele G; Tanweer, Omar; Mascitelli, Justin; Fragata, Isabel; Polifka, Adam; Osbun, Joshua; Crosa, Roberto; Matouk, Charles; Park, Min S; Brinjikji, Waleed; Moss, Mark; Williamson, Richard; Navia, Pedro; Kan, Peter; De Leacy, Reade; Chowdhry, Shakeel; Ezzeldin, Mohamad; Spiotta, Alejandro M; Levitt, Michael R; Yoshimura, Shinichi.
Affiliation
  • Matsukawa H; Department of Neurosurgery, Division of Neuroendovascular Surgery, Medical University of South Carolina, Charleston, USA; Department of Neurosurgery, Hyogo Medical University, Nishinomiya, Japan.
  • Uchida K; Department of Neurosurgery, Division of Neuroendovascular Surgery, Medical University of South Carolina, Charleston, USA; Department of Neurosurgery, Hyogo Medical University, Nishinomiya, Japan; Department of Clinical Epidemiology, Hyogo Medical University, Nishinomiya, Japan.
  • Cunningham C; Department of Neurosurgery, Hyogo Medical University, Nishinomiya, Japan.
  • Sowlat MM; Department of Neurosurgery, Division of Neuroendovascular Surgery, Medical University of South Carolina, Charleston, USA.
  • Elawady SS; Department of Neurosurgery, Division of Neuroendovascular Surgery, Medical University of South Carolina, Charleston, USA.
  • Maier I; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
  • Jabbour P; Department of Neurosurgery, Thomas Jefferson University Hospitals, Philadelphia, PA, USA.
  • Kim JT; Department of Neurology, Chonnam National University Medical School, Chonnam National University Hospital, Gwangju, South Korea.
  • Wolfe SQ; Department of Neurological Surgery, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  • Rai A; Department of Radiology, West Virginia School of Medicine, Morgantown, USA.
  • Starke RM; Department of Neurosurgery, University of Miami Health System, Miami, FL, USA.
  • Psychogios MN; Department of interventional and diagnostical Neuroradiology, University of Basel, Basel, Switzerland.
  • Shaban A; Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, USA.
  • Arthur A; Department of Neurosurgery, Semmes-Murphey Neurologic and Spine Clinic, University of Tennessee Health Science Center, Memphis, USA.
  • Cuellar H; Department of Neurosurgery and Neurointerventional Radiology, Louisiana State University, Shreveport, USA.
  • Howard BM; Emory University, Neurosurgery, Radiology and Imaging Sciences, Atlanta, USA.
  • Alawieh A; Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA, USA.
  • Romano DG; Department of Neuroradiology, University Hospital San Giovanni di Dio e Ruggi d'Aragona, University of Salerno, Salerno, Italy.
  • Tanweer O; Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA.
  • Mascitelli J; Department of Neurosurgery, University of Texas Health Science Center at San Antonio, San Antonio, USA.
  • Fragata I; Department of Neuroradiology, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
  • Polifka A; Department of Neurosurgery, University of Florida, Gainesville, USA.
  • Osbun J; Department of Neurological Surgery, Washington University, St Louis, MO, USA.
  • Crosa R; Department of Neurosurgery, Endovascular Neurological Center, Montevideo, Uruguay.
  • Matouk C; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
  • Park MS; Department of Neurosurgery, University of Virginia, Charlottesville, USA.
  • Brinjikji W; Department of Radiology, Mayo Clinic, Rochester, MN, USA; Department of Neurosurgery, Mayo Clinic, Rochester, USA.
  • Moss M; Department of Neuroradiology, Washington Regional J.B. Hunt Transport Services Neuroscience Institute, Fayetteville, AZ, USA.
  • Williamson R; Department of Neurosurgery, Allegheny Health Network, Pittsburgh, PA, USA.
  • Navia P; Department of Neuroradiology, Hospital Universitario La Paz, Madrid, Spain.
  • Kan P; Department of Neurological Surgery, University of Texas Medical Branch - Galveston, USA.
  • De Leacy R; Department of Neurosurgery, Mount Sinai Health System, New York, NY, USA.
  • Chowdhry S; Department of Neurosurgery, NorthShore University HealthSystem, Evanston, IL, USA.
  • Ezzeldin M; Department of Clinical Sciences, University of Houston, HCA Houston Healthcare Kingwood, TX, USA.
  • Spiotta AM; Department of Neurosurgery, Division of Neuroendovascular Surgery, Medical University of South Carolina, Charleston, USA.
  • Levitt MR; Department of Neurosurgery, University of Washington, Seattle, USA.
  • Yoshimura S; Department of Neurosurgery, Hyogo Medical University, Nishinomiya, Japan. Electronic address: hyogoneuro@yahoo.co.jp.
J Neurol Sci ; 462: 123054, 2024 May 31.
Article in En | MEDLINE | ID: mdl-38889600
ABSTRACT

BACKGROUND:

The outcomes of endovascular thrombectomy (EVT) for medium vessel occlusions (MeVOs) of specific vascular territories remain unknown. We aimed to investigate EVT outcomes by MeVO locations using the data from an ongoing international multicenter registry.

METHODS:

Patients with isolated MeVO who underwent EVT between January 2013 and December 2022 were retrospectively analyzed. Isolated MeVO was defined as an occlusion of the A2 or A3 (A2/A3), M2 or M3, and P2 or P3 (P2/P3). Outcomes included a 90-day modified Rankin score (mRS) of 0-2, successful recanalization (modified Thrombolysis in Cerebral Infarction score ≥ 2b), early neurological deterioration (END) or improvement (ENI), and 90-day mortality. END was defined as a worsening of ≥4 points from the baseline National Institutes of Health Stroke Scale (NIHSS) score within 24 h of EVT, while ENI was defined as an improvement of ≥4 points from the baseline NIHSS score within 24 h of EVT.

RESULTS:

1744 MeVOs included. Compared to M2 occlusions (n = 1542, 88.4%), A2/A3 (n = 36, 2.1%) occlusions had lower odds of 90-day mRS 0-2 (adjusted odds ratio [aOR] 0.30, 95% confidence interval [CI] 0.11-0.80), and P2/P3 occlusions (n = 49, 2.8%) had lower odds of successful recanalization (aOR 0.19, 95% CI 0.07-0.50), and higher odds of END (aOR 3.53, 95% CI 1.35-9.25). Other outcomes showed no significant differences.

CONCLUSIONS:

A2/A3 occlusions were more likely to have worse outcomes compared to M2 occlusions after EVT for patients with isolated MeVOs.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Neurol Sci Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Neurol Sci Year: 2024 Document type: Article Affiliation country:
...